The impact of aerosolized mucolytic agents on the airflow resistance of bacterial filters used in mechanical ventilation  by Hu, Han-Chung et al.
Journal of the Formosan Medical Association (2015) 114, 717e721Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.jfma-onl ine.comORIGINAL ARTICLEThe impact of aerosolized mucolytic agents
on the airflow resistance of bacterial filters
used in mechanical ventilationHan-Chung Hu a,b,c,d, Hsin-Chun Liu a,d, Yen-Huey Chen b,
Chung-Chi Huang a,b,c, Gwo-Hwa Wan b, Lan-Ti Chou a,
Meng-Jer Hsieh a,b,c, Ning-Hung Chen a,b,c, Cheng-Ta Yang a,b,c,
Kuo-Chin Kao a,b,c,*aDepartment of Respiratory Therapy, Chang Gung Memorial Hospital at Linkou, Chang Gung University,
College of Medicine, Taoyuan, Taiwan
bDepartment of Respiratory Therapy, Chang Gung University, College of Medicine, Taoyuan, Taiwan
cDepartment of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University, College of






mucolytic agents* Corresponding author. Department
Taiwan.
E-mail address: kck0502@adm.cgm
d These two authors share equal con
0929-6646/$ - see front matter Copyr
http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: In order to reduce the contamination in the ventilator, bacterial filters
were placed on the expiratory limb of a ventilator circuit. Aerosolized mucolytic agents may
increase the resistance of the ventilator. The goal of this study is to determine the impact
of aerosolized mucolytic agents on the pressure change during mechanical ventilation.
Methods: A lung model was investigated with mucolytic inhaled agents of 10% acetylcysteine
and 2% hypertonic saline. The agents were administered using a jet nebulizer every 45 minutes
for 15 minutes. The pressure drop was measured after nebulization. The end point was
referred to the 45th dose or obstruction of the filter. Furthermore, the pressure drop after
steam autoclaving was also measured.
Results: The maximum pressure was significantly higher with 10% acetylcysteine than with 2%
sodium chloride (39.32  7.22 cmH2O vs. 3.53  0.90 cmH2O, p < 0.001). With acetylcysteine
filters, the pressure drop over 4 cmH2O occurred earlier and had a good relationship between
the degree of pressure drop and doses. The acetylcysteine group yielded a significant differ-
ence in the pressure drop compared to the newly autoclaved and the end point of inhalation
(p Z 0.043).of Respiratory Therapy, Chang Gung Memorial Hospital, 5, Fu-Shin Street, Kwei-Shan, Taoyuan 333,
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718 H.-C. Hu et al.Conclusion: This study demonstrated the aerosolized mucolytic agents could increase the pres-
sure drop of the bacterial filters during mechanical ventilation. The pressure drop of the bac-
terial filters was higher with 10% acetylcysteine. It is critical to continuously monitor the
expiration resistance, auto-positive end-expiratory pressure, and ventilator output waveform
when aerosolized 10% acetylcysteine was used in mechanical ventilation patients.
Copyright ª 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Breathing system filters are expected to prevent the
transmission of microbes and other particulate substance in
breathing systems when the patient’s upper airway has
been bypassed during anesthesia and intensive care.1 In
order to reduce the risk of contaminating the ventilator
when mechanically ventilating a patient with suspected or
confirmed infectious disease, a bacterial filter was placed
on the expiratory limb of the breathing circuit of a
ventilator.2
Aerosolization of medications is the optimal route of
administration for some pulmonary diseases.3 Many aero-
solized medications could be administered after nebuliza-
tion, such as bronchodilators, steroid, antibiotics,
hypertonic saline, and mucolytic agents.48 Jet nebulizer
can be used during mechanical ventilation. The jet nebu-
lizer functions by passing compressed gas through a narrow
orifice and creating an area of low pressure at the outlet of
the adjacent liquid feed tube. This results in the drug so-
lution being drawn up from the fluid reservoir, which then
shatters into droplets in the gas stream.9
There is a potential adverse effect that aerosolized
particles can accumulate on the bacterial filter, increasing
the resistance to restrict the patient’s normal breathing
pattern. Some adverse reports indicated that the nebuli-
zation treatment caused the malfunction of the exhalation
valve or bacterial filter and patients could not exhale
properly.1012 A previous study had reported that the bac-
terial filter in a nebulizing system with bronchodilator
treatment such as salbutamol and ipratropium could be
safely employed.13 However, to the best of our knowledge,
there is very little research on nebulized mucolytic agents.
The goal of this study is to determine the impact of aero-
solized mucolytic agents on the bacterial filter during me-
chanical ventilation.Figure 1 Schematic representation of the experimental
apparatus.Materials and methods
Lung model and ventilator settings
To simulate the adult mechanical ventilation, the ventilator
(Galileo, Hamilton Medical, Switzerland) settings were
adjusted as follows: a tidal volume of 0.6 L, a respiratory
rate of 12 b/min, an inspiratory time of 1 second, positive
end-expiratory pressure (PEEP) of 5 cmH2O, and an inspi-
ratory flow rate of 54 L/min in a descending ramp flow
pattern. The ventilator alarm was set at a pressure of more
than 45 cmH2O, which implied that the filter would be
obstructed. This model included a ventilator circuit, acombined heat and moisture exchanger filter (Fig. 1,
collection filter) (Hygrobac S, Tyco Healthcare, Italy), and a
test lung [Training/Test Lung (TTL) Michigan Instruments,
Grand Rapids, Michigan] with lung mechanics of 0.05 L/
cmH2O compliance and 20 cmH2O/L/s resistance (Rp20
resistor; Fig. 1).
Filter and nebulizer
The brand new pleated hydrophobic filters (OmniFilter Tyco
Healthcare Eastern and Central Europe, Puritan-Bennett
Corporation, Pleasanton, CA, USA, diameter of 3.5 in.,
surface area of around 62.2 cm2) were located in the
exhalation limb closed to the ventilator (Fig. 1, exhalation
bacterial filter). The nebulizer was placed 6 in. from the Y-
piece adapter, using standard attachment corrugated
tubing (Fig. 1, aerosol generator). The aerosol generator
used here was a jet nebulizer (Neb-Easy Nebulizer Kit,
GaleMed, Wu-Jia, I-Lan, Taiwan). This device was fabri-
cated from acrylic and polypropylene plastics; it was
operated under the Venturi principle and was refillable.
The nebulizer had several attachments that came with it
during the nebulization process. These included a Tee
connector, which connected to the top of the nebulizer;
and a 6-inch corrugated tube, which connected to the side
of the Tee connector. A standard oxygen tube is connected
to the bottom of the nebulizer, which connected the
nebulizer to a pressurized gas source.
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Two types of mucolytic agents, 10% acetylcysteine and 2%
sodium chloride (hypertonic saline), were examined. The
inhaled agents were administered using a constant output
jet nebulizer every 45 minutes for 15 minutes. The aerosols
were administered sequentially without interruption. The
nebulizer was driven by oxygen at a flow of 6 L/min. The
administered agents in the two experimental groups were
10% acetylcysteine 3 mL/amp diluted with 1 mL of 0.45%
sodium chloride, and 4 mL of 2% sodium chloride. The
aerosol flow to the filters was kept constant by adjusting
the dosage.
In vitro measurements
Pressure drop is defined as the difference of the pressures
between filter inlet and outlet. The pressure drop was
measured against an air flow at 100 L/min by a flow
analyzer (PF 300, imtmedical, Buchs, Switzerland) prior to
and after each test. Furthermore, the pressure drop was
measured at 5 minute, 15 minute, and 30 minute points
after 15 minutes of nebulization. The end point was
referred to the 45th dose through the nebulizer or when the
filter was obstructed as indicated by the ventilator alarm.
Furthermore, the pressure drop after steam autoclaving
was also measured.
Data analysis
Student t test or Mann-Whitney U test (Wilcoxon rank-sum
test) were used to analyze the variance of pressure drop
for filters. The differences in pressure drop between the
baseline, the end point, and after steam autoclaving were
tested with Wilcoxon signed-rank test. Pearson correlation
test was used to determine if there was a correlation be-
tween the increases in pressure drop and dosage. Linear
regression was used to predict the pressure drop for one
dosage as a function of pressure drop. The statistic soft-
ware package SPSS version 17 (SPSS Inc., Chicago, IL, USA)
was used for all analysis, and p < 0.05 was considered
significant.
Results
Table 1 shows the pressure change through the filters with
two types of aerosolized agents, 10% acetylcysteine and 2%
sodium chloride. Five filters with nebulized 10% acetylcys-
teine and two filters with nebulized 2% sodium chlorideTable 1 Pressure differences in filters before and after
exposure to two mucolytic agents.
Pressure (cmH2O) Group A Group S p
Baseline 1.79  0.05 1.77  0.01 0.56
Maximum 39.32  7.22 3.53  0.90 0.001
Data are presented as mean  SD.
AZ 10% acetylcysteine; SZ 2% sodium chloride; SDZ standard
deviation.were examined. Prior to nebulization, the baseline pressure
was recorded for each filter. After starting nebulization,
pressure was recorded after each dose till the end point in
each filter. The baseline and maximum pressure with these
two types of aerosolized agents are summarized in Table 1.
With both aerosolized agents, the pressure change was
found to increase significantly after nebulization [inter-
quartile range (IQR): 2.46e9.00 cmH2O, p Z 0.013 in 10%
acetylcysteine and 2.29e3.03 cmH2O, p < 0.001 in 2% so-
dium chloride]. In addition, the maximum pressure was
significantly higher with 10% acetylcysteine than that
with 2% sodium chloride (39.32  7.22 cmH2O vs.
3.53  0.90 cmH2O, p < 0.001).
Fig. 2 reveals the degree of pressure drop in each filter
under different dosages. For the 2% sodium chloride filters
(S1 and S2), the degree of pressure drop was less than
4 cmH2O even with the 45th dose. However, for the 10%
acetylcysteine filters (A1eA5), the degree of pressure drop
over 4 cmH2O was reached between the 10
th and 17th doses.
Furthermore, Fig. 3 shows a good relationship between the
degree of pressure drop below 4 cmH2O and the dosage
(r Z 0.897e0.985, r2 Z 0.805e0.97, p < 0.001) in 10%
acetylcysteine filters.
Fig. 4 illustrates the degree of pressure drop through the
filters among baseline (condition 1), the end point (condi-
tion 2), and after steam autoclaving (condition 3) with
these two types of aerosolized agents. Comparing the de-
gree of pressure drop between the end point and after
steam autoclaving, 10% acetylcysteine groups yielded
significantly decreased pressure drop (p Z 0.043), but not
in 2% sodium chloride group (p Z 0.18). Besides, in 10%
acetylcysteine groups, the pressure drop between Condi-
tions 1 and 2, and Conditions 1 and 3 were also significantly
different (for both, p < 0.05).
Discussion
This study demonstrated that the aerosolized agents, 10%
acetylcysteine and 2% sodium chloride, could increase theFigure 2 Pressure drop under various inhalation dosages.
A1eA5 Z 10% acetylcysteine; S1eS2 Z 2% sodium chloride.
Figure 3 Linear regression between dosage and pressure
drop below 4 cmH2O in 10% acetylcysteine filters. A1eA5Z 10%
acetylcysteine.
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ventilation. However, the pressure drop over 4 cmH2O
through the filters was significant with 10% acetylcysteine
but not with 2% sodium chloride. The pressure drop over
4 cmH2O with 10% acetylcysteine was between the 10
th and
17th dosages. After steam autoclaving, the pressure drop of
the filters was significantly restored in 10% acetylcysteine
filters, but not in the 2% sodium chloride group.
Most studies in breathing system filters emphasized
filtration and penetration performance and the efficiency of
reducing the nosocomial infection rate. If the bacterial fil-
ters were obstructed by the aerosolized particles, the
increased resistance of bacterial filters in the ventilator
circuit would increase the airway resistance and work of
breathing on patients with mechanical ventilation. StudiesFigure 4 Comparison of pressure drop difference before
inhalation, after inhalation, and after steam autoclaving. X-
axis represents different filter status: 1: brand new; 2: at the
end point; 3: after steam autoclaving. * Implies difference in
Group A, Conditions 2 and 3, p Z 0.043. A Z 10% acetylcys-
teine; S Z 2% sodium chloride.have indicated that the pleated hydrophobic filter was su-
perior to the electrostatic filter in terms of bacterial and
viral filtration performance and the prevention of liquid
from passing through the filter layer.14e17 Breathing system
filters are intended to reduce the transmission of microbes
between the patient and the breathing system, and vice
versa. The pleated hydrophobic filters can be placed in the
breathing circuit in different positions. First, it can be
placed at the inhaled branch to avoid infection of the pa-
tient from the contaminated gas coming from the ventilator.
Second, it can be positioned at the exhaled branch to avoid
the contamination of the patient by retrograde spread of
microorganisms from the expiratory valve of the ventilator.
Third, it can be placed in between the Y-connector and
endotracheal tube to achieve the above two objectives. The
reusable pleated hydrophobic filter was designed as an
exhalation filter in a heated exhalation system in this study.
A previous study reported that bacterial filter in a
nebulizing system could be safely used with the inhalation
therapy of bronchodilators such as salbutamol and ipra-
tropium bromide.13 The characters of mucolytic agents
such as particle size, osmolarity, and viscosity were
different to the bronchodilator. To the best of our knowl-
edge, there is very little research on the effect of inhaled
mucolytic agents, such as acetylcysteine, on the intubated
patient. One case report revealed the risk of increasing
filter resistance by mucolytic agents such as acetylcysteine
with higher expiration resistance during mechanical venti-
lation.18 According to the manufacturer’s instructions of
the bacterial filter, they recommended the periodic
changing of the filter in 15 days and sterilization of the
filters through steam autoclaving.19 If regularly and
consistently administered nebulization therapy is given
three times a day for 15 days, the filter will endure the
maximum of 45 times of nebulization treatment. This
manufacturer’s instruction also suggests that it is critical to
inspect and check the pressure drop across the filter prior
to every reuse and the maximum allowable pressure drop
across the filter is below 4 cmH2O at 100 L/min.
19 In our
study, it has been observed that both 10% acetylcysteine
and 2% hypertonic saline inhalation agents would increase
the pressure drop across an exhalation filter. Throughout
the entire testing process, all five of the 10% acetylcysteine
filters were obstructed by the particles prior to the 45th
dose but not in two of the 2% sodium chloride filters. In the
group of 10% acetylcysteine filters, the end-point doses of
Filters 1e5 were the 18th, 19th, 27th, 24th, and 27th doses,
and the end-point pressure drops were up to 48.75 cmH2O,
37.72 cmH2O, 43.96 cmH2O, 36.07 cmH2O, and 30.1 cmH2O,
respectively. These observations suggest that carefully
monitor the exhalation filters is needed when nebulized
mucolytic agents, especially 10% acetylcysteine, are regu-
larly and consistently administered.
The test mucolytic agent, 10% acetylcysteine solution,
had a special odor and sticky appearance. Throughout the
entire study, the filters were inspected prior to the pressure
drop was checked. After multiple application, there was
some sticky substance coating inside the 10% acetylcysteine
filters and it appeared stickier than its original form. The
group of 2% sodium chloride filters was found to be coated
inside with some white powdery substance. A previous
study reported that the pressure drop across the filters
Mucolytic agents and airflow resistance 721would be significantly increased if the testing dosage
increased and the penetration performance decreased.20
The causes of the dramatically increasing pressure drop
across the filter by the nebulized 10% acetylcysteine might
be related to the quality and quantity of the solution.
In this study, the pressure drop of all the tested filters
was decreased after steam autoclaving. However, the 10%
acetylcysteine filters’ pressure drop could not return to the
manufacturer’s recommended value of less than 4 cmH2O.
It means that even if the pressure drop is better, the
functioning of the filter gets affected. This was because
those filters were already significantly obstructed by aero-
sol particles. The clinical implication is that it is critical to
continuously monitor the patient’s expiration resistance,
auto PEEP, and ventilator output waveform for early
detection of any related filter plugging, and to sterilize or
replace the filter accordingly.
There were some limitations in this study. First, the me-
chanical ventilator settings in this study were all constant
with the fixed tidal volume, respiratory rate, inspiratory
time, and flow rate. However, the parameters of mechanical
ventilator setting are variable in clinical practice and prob-
able to influence the performance of filters. Second, the
interval between courses of nebulization therapy in this
study was shorter than that in usual clinical practice. The
interval between courses of inhalation therapy was 45 mi-
nutes in the present study. However, in general clinical
practice, the frequency of nebulization mucolytic therapy is
three times in a day, and the interval is every 6e12 hours.
Third, the characteristics of the nebulization agent such as
osmolarity and aerosolized particle size were not addressed
in this in vitro study. These factors would be important to
influence the filter resistance. Finally, this was a lung model
study and direct application of these data to the clinical
practice is limited. It is necessary to further confirm the
observation in this study in clinical settings.
In conclusion, the aerosolized mucolytic agent inhala-
tion via jet continuous output nebulizer would increase the
resistance of the bacterial filters at the end of exhalation
limb during mechanical ventilation. The resistance of the
bacterial filters after aerosolized inhalation was signifi-
cantly increased with 10% acetylcysteine agent than with
2% sodium chloride agent and the filters are still out of
function even after steam autoclaving. In clinical practice,
it is critical to continuously monitor the expiration resis-
tance, auto PEEP, and ventilator output waveform when
aerosolized 10% acetylcysteine was used in patients with
mechanical ventilation.References
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